Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer

被引：0
|
作者：
Yusuf, Syed W. [1 ]
Kim, Peter [1 ]
Durand, Jean-Bernard [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2367 / 2367
页数：1
相关论文
共 50 条
  • [21] Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib
    Cho, Byoung Chul
    Im, Chong-Kun
    Park, Moo-Suk
    Kim, Se Kyu
    Chang, Joon
    Park, Jong Pil
    Choi, Hye Jin
    Kim, Yu Jin
    Shin, Sang-Joon
    Sohn, Joo Hyuk
    Kim, Hoguen
    Kim, Joo Hang
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2528 - 2533
  • [22] Is erlotinib really active after failure of gefitinib in advanced non-small-cell lung cancer patients?
    Vasile, E.
    Tibaldi, C.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2009, 20 (04) : 790 - 791
  • [23] Erlotinib response EGFR-mutant gefitinib-resistant non-small-cell lung cancer
    Chang, John Wen-Cheng
    Chou, Chun-Liang
    Huang, Shiu-Feng
    Wang, Hung-Ming
    Hsieh, Jia-Juan
    Hsu, Todd
    Cheung, Yun-Chung
    LUNG CANCER, 2007, 58 (03) : 414 - 417
  • [24] Gefitinib or erlotinib in previously treated non-small-cell lung cancer patients: a cohort study in Taiwan
    Chang, Chia-Hao
    Lee, Chih-Hsin
    Ko, Jen-Chung
    Chang, Lih-Yu
    Lee, Ming-Chia
    Wang, Jann-Yuan
    Yu, Chong-Jen
    CANCER MEDICINE, 2017, 6 (07): : 1563 - 1572
  • [25] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
  • [26] Gefitinib for refractory advanced non-small-cell lung cancer
    Moriguchi, H
    Kim, TY
    Sato, C
    LANCET, 2006, 367 (9507): : 299 - 300
  • [27] Biomarkers of response to gefitinib in non-small-cell lung cancer
    Carbone, David P.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (02): : 66 - 67
  • [28] Gefitinib plus clocetaxel in non-small-cell lung cancer
    Zalcman, Gerard
    Bergot, Emmanuel
    LANCET, 2009, 373 (9663): : 541 - 541
  • [29] Biomarkers of response to gefitinib in non-small-cell lung cancer
    David P Carbone
    Nature Clinical Practice Oncology, 2004, 1 : 66 - 67
  • [30] Erlotinib As Maintenance Monotherapy in Non-Small-Cell Lung Cancer
    Muir, Victoria J.
    Dhillon, Sohita
    BIODRUGS, 2011, 25 (03) : 139 - 146
12345